EBITDA Summary of CHC Healthcare Group

CHC Healthcare Group's latest annual EBITDA in 2023 was 1.24 Billion TWD , up 17.43% from previous year.
CHC Healthcare Group's latest quarterly EBITDA in 2024 Q2 was 220.81 Million TWD , up 20.83% from previous quarter.
CHC Healthcare Group reported an annual EBITDA of 1.04 Billion TWD in 2022, up 4.35% from previous year.
CHC Healthcare Group reported an annual EBITDA of 998.31 Million TWD in 2021, up 3.16% from previous year.
CHC Healthcare Group reported a quarterly EBITDA of 188.57 Million TWD for 2024 Q1, down -56.45% from previous quarter.
CHC Healthcare Group reported a quarterly EBITDA of N/A for 2023 FY, up 17.43% from previous quarter.

Annual EBITDA Chart of CHC Healthcare Group (2023 - 2009)

Historical Annual EBITDA of CHC Healthcare Group (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	1.24 Billion TWD	17.43%
2022	1.04 Billion TWD	4.35%
2021	998.31 Million TWD	3.16%
2020	982.82 Million TWD	3.78%
2019	962.65 Million TWD	13.95%
2018	883.36 Million TWD	74.1%
2017	485.37 Million TWD	-31.15%
2016	696.32 Million TWD	-6.07%
2015	738.61 Million TWD	2.78%
2014	718.63 Million TWD	-2.32%
2013	735.67 Million TWD	-13.83%
2012	854.52 Million TWD	-8.33%
2011	935.83 Million TWD	18.86%
2010	778.97 Million TWD	3795.29%
2009	20.1 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	220.81 Million TWD	20.83%
2024 Q1	188.57 Million TWD	-56.45%
2023 FY	- TWD	17.43%
2023 Q2	303.36 Million TWD	9.49%
2023 Q3	234.4 Million TWD	-22.73%
2023 Q4	428.32 Million TWD	82.72%
2023 Q1	277.08 Million TWD	4.97%
2022 Q2	269.46 Million TWD	8.33%
2022 Q1	248.74 Million TWD	-19.49%
2022 FY	- TWD	4.35%
2022 Q4	263.96 Million TWD	-4.52%
2022 Q3	276.46 Million TWD	2.59%
2021 Q2	217.99 Million TWD	-20.17%
2021 Q1	273.07 Million TWD	38.8%
2021 FY	- TWD	3.16%
2021 Q4	308.94 Million TWD	44.04%
2021 Q3	214.48 Million TWD	-1.61%
2020 Q2	236.25 Million TWD	5.02%
2020 FY	- TWD	3.78%
2020 Q4	196.74 Million TWD	-39.55%
2020 Q3	325.48 Million TWD	37.77%
2020 Q1	224.96 Million TWD	19.49%
2019 Q4	188.26 Million TWD	-39.65%
2019 FY	- TWD	13.95%
2019 Q1	194.99 Million TWD	27.29%
2019 Q2	252.43 Million TWD	29.46%
2019 Q3	311.93 Million TWD	23.57%
2018 Q2	263.23 Million TWD	77.07%
2018 Q1	148.65 Million TWD	372.14%
2018 FY	- TWD	74.1%
2018 Q3	263.86 Million TWD	0.24%
2018 Q4	153.18 Million TWD	-41.95%
2017 Q4	-54.62 Million TWD	-133.75%
2017 FY	- TWD	-31.15%
2017 Q3	161.85 Million TWD	3.57%
2017 Q1	214.17 Million TWD	-21.44%
2017 Q2	156.27 Million TWD	-27.03%
2016 Q4	272.63 Million TWD	91.44%
2016 Q1	128.8 Million TWD	-45.67%
2016 Q2	149.95 Million TWD	16.42%
2016 Q3	142.41 Million TWD	-5.03%
2016 FY	- TWD	-6.07%
2015 Q4	237.08 Million TWD	13.45%
2015 Q2	242.8 Million TWD	388.04%
2015 Q1	49.75 Million TWD	-79.17%
2015 FY	- TWD	2.78%
2015 Q3	208.96 Million TWD	-13.94%
2014 Q4	238.81 Million TWD	66.06%
2014 Q3	143.81 Million TWD	-26.25%
2014 Q2	195 Million TWD	38.3%
2014 Q1	141 Million TWD	-28.88%
2014 FY	- TWD	-2.32%
2013 Q1	96.48 Million TWD	-64.4%
2013 Q2	197.03 Million TWD	104.22%
2013 Q3	243.88 Million TWD	23.77%
2013 Q4	198.26 Million TWD	-18.7%
2013 FY	- TWD	-13.83%
2012 Q2	224.48 Million TWD	86.12%
2012 Q1	120.61 Million TWD	-87.05%
2012 Q3	237.85 Million TWD	5.96%
2012 FY	- TWD	-8.33%
2012 Q4	271.03 Million TWD	13.95%
2011 FY	- TWD	18.86%
2011 Q4	931.39 Million TWD	0.0%
2011 Q3	- TWD	0.0%
2010 FY	- TWD	3795.29%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of CHC Healthcare Group

Name	EBITDA	EBITDA Difference

Global Stocks Search

CHC Healthcare Group (4164.TW)

EBITDA Summary of CHC Healthcare Group

Annual EBITDA Chart of CHC Healthcare Group (2023 - 2009)

Historical Annual EBITDA of CHC Healthcare Group (2023 - 2009)

Peer EBITDA Comparison of CHC Healthcare Group